ZTS Zoetis Inc
Company Analysis
Latest News
Zoetis Downgraded as Jefferies Cuts Target to $83 on Pricing Risks
Jefferies downgraded Zoetis (NYSE: ZTS) from Buy to Hold and cut its price target from $103 to $83. Shares fell in pre-market trading. The firm cited concerns...
🔴 Zoetis is trading 12.05% down in after-hours trading; cause unclear
Zoetis is trading 12.05% down at $70.00 after-hours; the cause of the October 19 decline remains unclear, with no verified company-specific announcement...
🟢 Zoetis is trading 4.2% up today as investors favor healthcare amid inflation concerns
Zoetis is trading at $78.44, up 4.19%, as healthcare shares gain in a defensive rotation. - Investors are responding to hotter-than-expected inflation data and...
🔴 Zoetis is trading 6.8% down in after-hours trading with no confirmed cause
Zoetis is trading 6.8% down at $69.27 after hours, with the cause unclear. - No confirmed company-specific announcement explains the move; the October 13 board...
Zoetis Hits 52-Week Low Amid Analyst Price Target Cuts
Zoetis (ZTS) shares hit a new 52-week low on September 21, 2026. The stock traded as low as $70.54. The decline follows cautious analyst updates amid a...
🔴 Zoetis is trading 5.64% down in after-hours trading amid softer companion-animal demand and tougher competition
Zoetis is trading at $69.27 (-5.64%) after management highlighted softer companion-animal demand and tougher competition. - At the September 14 Morgan Stanley...
Value Investor Tweedy Browne Takes New $40M Stake in Zoetis (ZTS)
Following the value-oriented investment philosophy of Benjamin Graham, Tweedy Browne established a new position in Zoetis, the world's largest producer of...
David Rolfe's Wedgewood Partners exits its entire Zoetis (ZTS) position
In a recent 13F filing, David Rolfe's Wedgewood Partners revealed it had sold its entire stake in animal health company Zoetis. The filing, which reflects...
🟢 Zoetis is trading 4% up today on a healthcare-sector rally
Zoetis is trading 4.01% up at $78.03, with the gain aligned with healthcare-sector strength. - XLV is up 1.29%, alongside modestly positive major indexes and...
Polen Capital Slashes Zoetis Stake by 92%
In a significant portfolio shift, Polen Capital Management reduced its holding in animal health company Zoetis by 92.41% during the second quarter of 2026....
🟢 Zoetis is trading 4.07% up today as healthcare stocks rally
Zoetis is trading 4.07% up now at $77.31 as healthcare stocks rally. - Healthcare gains reflect improving earnings expectations, attractive valuations,...
Tweedy Browne's Q2 13F: New Stake in Zoetis, Exits Sealed Air, Trims FedEx
In its second-quarter 13F filing, Tweedy Browne revealed a portfolio valued at $1.32 billion, a slight increase from the previous quarter. The firm, known for...
Terry Smith's Fundsmith exits $458M stake in animal health giant Zoetis
Terry Smith's Fundsmith has completely sold its position in Zoetis (ZTS), the world's largest producer of medicine and vaccinations for pets and livestock. An...
🔴 Zoetis is trading 6.4% down in after-hours trading amid broader market sell-off
Zoetis is trading 6.4% down at $69.27 after the broader market sold off on August 18, 2026. - Technology-led weakness, rising Treasury yields, higher oil...
🔴 Zoetis is trading 4.1% down today after lower 2026 adjusted EPS guidance
Zoetis is trading 4.1% down at $72.27, despite broader U.S. indexes trading higher, after the company lowered 2026 adjusted EPS guidance. - Following the...
Zoetis Slashes Its 2026 Outlook for the Second Time — Can the Pet-Health Giant Stop the Bleeding?
Shares of Zoetis cratered 6.3% to $72.38 on August 7, bucking a broadly rising market, after the world's largest animal-health company cut its full-year...
🔴 Zoetis is trading 6.33% down today after cutting 2026 revenue and EPS guidance
Zoetis is trading 6.33% down at $72.38 after investors reacted to its August 6 earnings release and sharply reduced 2026 outlook. - Second-quarter revenue was...
Zoetis Appoints James Saccaro as Executive Vice President, CFO and COO
Zoetis announced the appointment of James Saccaro to the newly created role of Executive Vice President, Chief Financial Officer and Chief Operating Officer,...
🟢 Zoetis is trading 4.03% up today despite reduced 2026 EPS guidance
Zoetis is trading 4.03% up at $77.39, with the gain appearing partly supported by healthcare-sector strength despite mixed second-quarter results and reduced...
Zoetis second quarter revenue of $2.47B misses estimates as company cuts full-year 2026 guidance on companion animal weakness.
Zoetis reported flat second quarter revenue of $2.47 billion, missing consensus estimates of $2.51 billion. Adjusted EPS came in at $1.87, slightly ahead of...